胎儿宫内干预技术在改善缺陷胎儿预后中的应用

陈功立, 杨勇, 周玮

中国实用妇科与产科杂志 ›› 2026, Vol. 42 ›› Issue (2) : 162-166.

PDF(1025 KB)
PDF(1025 KB)
中国实用妇科与产科杂志 ›› 2026, Vol. 42 ›› Issue (2) : 162-166. DOI: 10.19538/j.fk2026020109
专题笔谈

胎儿宫内干预技术在改善缺陷胎儿预后中的应用

作者信息 +

Application of fetal intervention techniques in improving the prognosis of fetuses with defects

Author information +
文章历史 +

摘要

胎儿宫内干预技术将治疗关口从出生后前移至胎儿时期,可改善部分缺陷胎儿的预后,是出生缺陷的重要防控手段。文章结合当前循证医学证据,系统梳理胎儿宫内干预的核心技术体系,分析临床实践中的关键问题与伦理挑战,展望未来发展方向,为临床决策与研究探索提供参考。

Abstract

Fetal intervention techniques shift the threshold of treatment from the postnatal period to the fetal stage. It can improve the prognosis of some fetuses with congenital defects and serves as a crucial means for the prevention and control of birth defects. Based on the current evidence-based medical evidence,this article systematically outlines the core technical framework of fetal intervention,analyzes the key issues and ethical challenges in clinical practice,and explores future development directions,offering reference for clinical decision-making and further research.

关键词

胎儿宫内干预 / 胎儿外科 / 出生缺陷 / 胎儿医学 / 宫内治疗

Key words

fetal intervention / fetal surgery / birth defects / fetal medicine / fetal treatment

引用本文

导出引用
陈功立, 杨勇, 周玮. 胎儿宫内干预技术在改善缺陷胎儿预后中的应用[J]. 中国实用妇科与产科杂志. 2026, 42(2): 162-166 https://doi.org/10.19538/j.fk2026020109
CHEN Gong-li, YANG Yong, ZHOU Wei. Application of fetal intervention techniques in improving the prognosis of fetuses with defects[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2026, 42(2): 162-166 https://doi.org/10.19538/j.fk2026020109
中图分类号: R714.5   

参考文献

[1]
Varthaliti A, Pergialiotis V, Theodora M, et al. Advances in fetal surgery:a narrative review of therapeutic interventions and future directions[J]. Medicina (Kaunas), 2025, 61(7):1136. DOI:10.3390/medicina61071136.
[2]
Society for Maternal-Fetal Medicine(SMFM), Miller RS, Miller JL, et al. Society for Maternal-Fetal Medicine consult series #72:twin-twin transfusion syndrome and twin anemia-polycythemia sequence[J]. Am J Obstet Gynecol, 2024, 231(4):B16-B37. DOI:10.1016/j.ajog.2024.07.017.
[3]
de Azevedo Teixeira LK, Provinciatto H, Callado GY, et al. Fetal Surgery for congenital heart diseases:a systematic review and single-arm meta-analysis[J]. Adv Ther, 2025, 42(12):6150-6162. DOI:10.1007/s12325-025-03388-0.
[4]
Kunpalin Y, Subramaniam S, Perin S, et al. Preclinical stem cell therapy in fetuses with myelomeningocele:A systematic review and meta-analysis[J]. Prenat Diagn, 2021, 41(3):283-300. DOI:10.1002/pd.5887.
[5]
吴玉珍, 孙念怙, 王凤云. 应用胎儿镜诊断胎儿白化病14例报告[J]. 中华妇产科杂志, 1998,(8):482. DOI:10.3760/j.issn:0529-567X.1998.08.010.
[6]
杨勇, 梁志清, 漆洪波, 等. 胎儿镜气管封堵术治疗胎儿重度先天性膈疝6例临床分析[J] .中华妇产科杂志, 2023, 58(12):939-943. DOI:10.3760/cma.j.cn112141-20230821-00059.
[7]
Wang H, Luo W, Gongli C. Fetal therapy for severe drug-resisted tachyarrhythmia with progressive hydrops by fetoscopic transesophageal pacing:a successful attempt in single chinese fetal medicine center[J]. Prenatal diagnosis, 2025, 45(5):652-655. DOI:10.1002/pd.6745.
[8]
Zhao L, Wang L, Xia H, et al. Prognosis and outcome of intrauterine treatment of fetuses with critical congenital heart disease[J]. Chin Med J(Engl), 2024, 137(12):1431-1436. DOI:10.1097/cm9.0000000000002796.
[9]
邱婉宁, 原鹏波, 魏瑗. 复杂性双胎宫内干预技术应用进展[J]. 中国实用妇科与产科杂志, 2025, 41(2):42-147.DOI:10.19538/j.fk2025020104.
[10]
Xu X, Qin F, Li L, et al. Placental rupture after fetoscopic SOLOMON technique for twin-twin transfusion syndrome:2 cases report[J]. BMC Pregnancy Childbirth, 2025, 25(1):345. DOI:10.1186/s12884-025-07487-2.
[11]
Zani A, Chung WK, Deprest J, et al. Congenital diaphragmatic hernia[J]. Nat Rev Dis Primers, 2022, 8(1):37. DOI:10.1038/s41572-022-00362-w.
[12]
Deprest JA, Nicolaides KH, Benachi A, et al. Randomized trial of fetal surgery for severe left diaphragmatic hernia[J]. N Engl J Med, 2021, 385(2):107-118. DOI:10.1056/NEJMoa2027030.
[13]
陈功立, 漆洪波. 重度胎儿膈疝的宫内治疗:中国实践[J]. 临床儿科杂志, 2024, 42(1):24-27. DOI:10.12372/jcp.2024.23e0877.
[14]
Paslaru FG, Panaitescu AM, Iancu G, et al. Myelomeningocele surgery over the 10 years following the MOMS Trial:a systematic review of outcomes in prenatal versus postnatal surgical repair[J]. Medicina (Kaunas), 2021, 57(7):707. DOI:10.3390/medicina57070707.
[15]
泮思林, 罗刚. 推进中国胎儿结构性心脏病宫内干预的相关问题与对策[J]. 中国实用儿科杂志, 2021, 36(5):332-335.DOI:10.19538/j.ek2021050604.
[16]
Capone V, Persico N, Berrettini A, et al. Definition,diagnosis and management of fetal lower urinary tract obstruction:consensus of the ERKNet CAKUT-Obstructive Uropathy Work Group[J]. Nat Rev Urol, 2022, 19(5):295-303. DOI:10.1038/s41585-022-00563-8.
[17]
Ruano R. Prenatal regenerative fetoscopic interventions for congenital anomalies[J]. BMJ, 2020,370:m1624. DOI:10.1136/bmj.m1624.
[18]
Prefumo F, Fichera A, Fratelli N, et al. Fetal anemia:diagnosis and management[J]. Best Pract Res Clin Obstet Gynaecol, 2019, 58:2-14. DOI:10.1016/j.bpobgyn.2019.01.001.
[19]
Abels EA. Management of red cell alloimmunization in pregnancy[J]. Obstet Gynecol, 2024, 144(4):465-480. DOI:10.1097/aog.0000000000005709.
[20]
Society for Maternal-Fetal Medicine, Gandhi M, Rac MWF, et al. Amniotic band sequence[J]. Am J Obstet Gynecol, 2019, 221(6):B5-B6. DOI:10.1016/j.ajog.2019.09.020.
[21]
杨勇, 陈功立. 胎儿羊膜带综合征10例诊治分析[J]. 中华小儿外科杂志, 2025, 46(5):407-412. DOI:10.3760/cma.j.cn421158-20240915-00394.
[22]
Yi L, Wan C, Deng C, et al. Changes in prevalence and perinatal outcomes of congenital hydrocephalus among Chinese newborns:a retrospective analysis based on the hospital-based birth defects surveillance system[J]. BMC Pregnancy Childbirth, 2017, 17(1):406. DOI:10.1186/s12884-017-1603-2.
[23]
Murray C, Nicolaides K, Bleil C, et al. Surgical interventions for fetal hydrocephalus:systematic review[J]. Ultrasound Obstet Gynecol, 2025, 66(4):413-421. DOI:10.1002/uog.29310.
[24]
Hu Q, Liao H, Xu T, et al. Perinatal outcomes of intrauterine fetal arrhythmias:A 10-year retrospective cohort study[J]. Medicine, 2023, 102(10):e33244. DOI:10.1097/md.0000000000033244.
[25]
Joglar JA, Kapa S, Saarel EV, et al. 2023 HRS expert consensus statement on the management of arrhythmias during pregnancy[J]. Heart rhythm,2023, 20(10):e175-e264. DOI:10.1016/j.hrthm.2023.05.017.
[26]
Batra AS, Silka MJ, Borquez A, et al. Pharmacological management of cardiac arrhythmias in the fetal and neonatal periods:a scientific statement from the American Heart Association:endorsed by the Pediatric & Congenital Electrophysiology Society (PACES)[J]. Circulation, 2024, 149(10):e937-e952. DOI:10.1161/cir.0000000000001206.
[27]
Victoria T, Johnson AM, Moldenhauer JS, et al. Imaging of fetal tumors and other dysplastic lesions:A review with emphasis on MR imaging[J]. Prenat Diagn, 2020, 40(1):84-99. DOI:10.1002/pd.5630.
[28]
Cianci MC, Fusi G, Morini F, et al. Fetal treatment of sacrococcygeal teratoma:state of the art[J]. Front Pediatr, 2025, 13:1410269. DOI:10.3389/fped.2025.1410269.
[29]
Brown MF, Lewis D, Brouillette RM, et al. Successful prenatal management of hydrops,caused by congenital cystic adenomatoid malformation,using serial aspirations[J]. J Pediatric Surg, 1995, 30(7):1098-1099. DOI:10.1016/0022-3468(95)90350-x.
[30]
Buca D, Iacovella C, Khalil A, et al. Perinatal outcome of pregnancies complicated by placental chorioangioma:systematic review and meta-analysis[J]. Ultrasound Obstet Gynecol, 2020, 55(4):441-449. DOI:10.1002/uog.20304.
[31]
Swearingen C, Colvin ZA, Leuthner SR. Nonimmune hydrops fetalis[J]. Clin Perinatol, 2020, 47(1):105-21. DOI:10.1016/j.clp.2019.10.001.
[32]
Lago Leal V, Cortés LM, Seco Del Cacho C. Prenatal diagnosis of congenital high airway obstruction syndrome[J]. Indian J Radiol Imaging, 2018, 28(3):366-368. DOI:10.4103/ijri.IJRI_396_16.
[33]
Bellieni CV. New insights into fetal pain[J]. Semin Fetal Neonatal Med, 2019, 24(4):101001. DOI:10.1016/j.siny.2019.04.001.
[34]
Bano S, Casella A, Vasconcelos F, et al. Placental vessel segmentation and registration in fetoscopy:Literature review and MICCAI FetReg2021 challenge findings[J]. Med Image Anal, 2024, 92:103066. DOI:10.1016/j.media.2023.103066.
[35]
陈艳红, 陈敦金. 人工智能——助力产科服务提升[J]. 中国实用妇科与产科杂志, 2024, 40(10):964-968.DOI:10.19538/j.fk2024100102.

脚注

利益冲突 所有作者均声明不存在利益冲突

基金

国家重点研发计划(2023YFC2705904)

PDF(1025 KB)

Accesses

Citation

Detail

段落导航
相关文章

/